XOMA Enters into License Agreement with Merck & Co., Inc.
21-Jun-2005 -
XOMA Ltd. announced that it has granted Merck & Co., Inc. (Merck) a non-exclusive, worldwide license for XOMA's antibody-related intellectual property. Under the agreement, Merck receives a license to use XOMA's bacterial cell expression intellectual property for phage display with potential use ...
antibody fragments
bacteria
immunoglobulins
+4